Search results
Results from the WOW.Com Content Network
In 2007, Timothy Paul Jones wrote a book-length response to Misquoting Jesus, called Misquoting Truth: A Guide to the Fallacies of Bart Ehrman's "Misquoting Jesus". It was published by InterVarsity Press. Novum Testamentum suggested that Misquoting Truth was a useful example of how conservative readers have engaged Ehrman's arguments. [12]
[13] [14] Misquoting Truth was the first book-length response to Misquoting Jesus, a bestselling introduction to biblical textual criticism authored by Bart D. Ehrman. In a review of Misquoting Truth, Tim Challies stated that Jones had demonstrated that "not only are Ehrman’s arguments far from original, they are also, quite simply fallacious."
Mometasone, also known as mometasone furoate, is a steroid (specifically, a glucocorticoid) medication used to treat certain skin conditions, hay fever, and asthma. [ 10 ] [ 11 ] [ 12 ] Specifically it is used to prevent rather than treat asthma attacks. [ 10 ]
Another criticism raised, which was also raised over Misquoting Jesus, is that Ehrman implies that the information being presented is new, or groundbreaking. United Methodist bishop William H. Willimon says that "He keeps presenting this stuff as if this is wonderful new knowledge that has been kept from you backward lay people and this is the ...
I have just modified one external link on Misquoting Jesus. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
In 2007 Lost in Transmission was published as a response to Bart Ehrman's popular Misquoting Jesus dealing with issues of textual criticism of the New Testament. In 2008 Perrin delivered a public lecture on the historical Jesus at the University of Georgia.
Mometasone/formoterol, sold under the brand name Dulera among others, is a fixed-dose combination medication used in the long-term treatment of asthma. [1] It contains mometasone a steroid and formoterol a long-acting beta agonist. [1] It is only recommended in those for whom an inhaled steroid is not sufficient. [1] It is used by inhalation. [1]
It is the first asthma triple-combination therapy; it consists of a fixed-dose combination of three active substances (indacaterol, glycopyrronium bromide and mometasone furoate) in capsules, to be administered using an inhaler. [11] An optional electronic sensor may also be co-packed with the product. [11]